Treatment of Hyperoxaluria in Patients with Jejunoileal Bypass: Effects of Calcium, Aluminum, Magnesium and Cholestyramine

  • B. Nordenvall
  • L. Backman
  • L. Larsson
  • H.-G. Tiselius
Conference paper


Hyperoxaluria and calcium oxalate stones are common following intestinal resection1 and jejunoileal bypass operations2,3. A high intestinal absorption of oxalate appears to be responsible for the hyperoxaluria4,5. Diets low in oxalate5 and fat4 have been recommended to reduce oxalate excretion, but may be difficult to adhere to because of unpalatability6. Oral administration of calcium7, aluminium6, magnesium8 and cholestyramine9 have been reported to decrease oxalate excretion in patients with enteric hyperoxaluria, but none of these studies was performed under ambulatory conditions. This study describes the effects of these treatments on the urinary composition of patients with hyperoxaluria after jejunoileal bypass operation under out-patient conditions.


Urinary Excretion Urinary Oxalate Jejunoileal Bypass Calcium Oxalate Stone Oxalate Excretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. W. Dobbins and H. J. Binder, in: “Progress in Gastroenterology”, Vol. 3. G. B. J. Glass, ed., Grune and Stratton, New York (1977).Google Scholar
  2. 2.
    L. Backman, B. Nordenvall, and D. Hallberg, Urol. Res. 7:189 (1979).PubMedCrossRefGoogle Scholar
  3. 3.
    J. Gregory, K. Park, and H. Schoenberg, J. Urol. 117:631 (1977).PubMedGoogle Scholar
  4. 4.
    H. Andersson and R. Jagenburg, Gut 15:360 (1974).PubMedCrossRefGoogle Scholar
  5. 5.
    D. L. Earnest, G. Johnson, H. E. Williams, and W. Admirand, Gastroenterology 66:1114 (1974).PubMedGoogle Scholar
  6. 6.
    D. L. Earnest, H. E. Williams, and W. H. Admirand, Trans. Assoc. Am. Physcns. 88:224 (1975).Google Scholar
  7. 7.
    J. Q. Stauffer, Dig. Dis. 22:921 (1977).CrossRefGoogle Scholar
  8. 8.
    D. E. Barilla, C. Notz, D. Kennedy, and C. Y. C. Pak, Am. J. Med. 64:579 (1978).PubMedCrossRefGoogle Scholar
  9. 9.
    J. Q. Stauffer, M. H. Humphreys, and G. J. Wie, Ann. Int. Med. 79:383 (1973).PubMedGoogle Scholar
  10. 10.
    M. Buchwald and R. L. Varco, Surgery 70:62 (1971).PubMedGoogle Scholar
  11. 11.
    H.-G. Tiselius, Invest. Urol. 15:5 (1977).PubMedGoogle Scholar
  12. 12.
    D. L. Trudeau and E. F. Freier, Clin. Chim. 13:101 (1967).Google Scholar
  13. 13.
    J. L. Hansen and E. F. Freier, Am. J. Med. Tech. 33:158 (1967).Google Scholar
  14. 14.
    B. W. Greenbaum and N. Pace, Microchem. J. 15:673 (1970).CrossRefGoogle Scholar
  15. 15.
    H.-G. Tiselius, L. E. Almgard, L. Larsson, and B. Sorbo, Eur. Urol. 4:241 (1978).PubMedGoogle Scholar
  16. 16.
    B. Nordenvall, L. Backman, and L. Larsson, Scand. J. Gastroenterol. 16:395 (1981).PubMedCrossRefGoogle Scholar
  17. 17.
    M. J. Binder, Gastroenterology 67:441 (1974).PubMedGoogle Scholar
  18. 18.
    M. Lotz, E. Zisman, and F. C. Bartter, New Engl. J. Med. 278:409 (1968).PubMedCrossRefGoogle Scholar
  19. 19.
    S. Das, B. Joseph, and A. Dick, J. Urol. 121:506 (1979).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • B. Nordenvall
    • 1
  • L. Backman
    • 1
  • L. Larsson
    • 1
  • H.-G. Tiselius
    • 2
  1. 1.Dept. of SurgeryKarolinska Institute at Danderyd HospitalStockholmSweden
  2. 2.Dept. of Clinical Chemistry and Dept. of UrologyUniversity HospitalLinköpingSweden

Personalised recommendations